具有自身免疫特征的间质性肺炎:风湿病学与肺病学交叉领域的新挑战
本文综述了2015年美国胸科学会与欧洲呼吸学会提出的具有自身免疫特征的间质性肺炎(IPAF)分类标准的历史背景、当前标准的局限性、诊断挑战、治疗选择及疾病监测策略。风湿病学家在评估潜在IPAF患者中起关键作用,许多肌炎谱疾病患者按现行炎性肌病标准会被归类为IPAF,因而可从风湿病学共同管理中获益。
要点
- 2015年ATS/ERS提出IPAF分类标准,用于识别以肺部受累为主但不符合系统性风湿病分类标准的CTD患者。
- 许多肌炎谱疾病患者(如非Jo-1抗合成酶综合征、抗MDA5抗体炎性肌病、抗PM/Scl抗体相关炎性肌病)按现行炎性肌病标准会被归类为IPAF。
- 风湿病学家在IPAF评估中起关键作用,这类患者可从风湿病学共同管理中获益。
核心结论
- IPAF标准虽不完美,但是为未分化疾病患者分类以供未来研究的重要尝试。
研究设计与样本
- 综述,描述2015年美国胸科学会与欧洲呼吸学会提出的IPAF分类标准的历史背景、局限性、诊断挑战、治疗选择及监测策略。
主要发现
- 部分患者不符合系统性风湿病分类标准但仍可从免疫抑制治疗中获益。
- 许多肌炎谱疾病患者按现行炎性肌病标准会被归类为IPAF,因而可从风湿病学共同管理中获益。
关键数值与推荐
- 2015年美国胸科学会与欧洲呼吸学会描述了IPAF分类标准,用于识别以肺部受累为主但缺乏足够系统性风湿病特征以满足分类标准的CTD患者。
临床怎么用
- 风湿病学家在评估潜在IPAF患者中起关键作用。
- 许多肌炎谱疾病患者按现行炎性肌病标准会被归类为IPAF,可从风湿病学共同管理中获益。
局限性
- 原文述及当前IPAF标准并不完美。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interstitial lung disease (ILD) remains a cause of significant morbidity and mortality in patients with connective tissue disease (CTD)-associated ILD. While some patients meet clear classification criteria for a systemic rheumatic disease, a subset of patients do not meet classification criteria but still benefit from immunosuppressive therapy. In 2015, the American Thoracic Society and European Respiratory Society described classification criteria for interstitial pneumonia with autoimmune features (IPAF) to identify patients with lung-predominant CTD who lack sufficient features of a systemic rheumatic disease to meet classification criteria. Although these criteria are imperfect, they are an important attempt to classify the patient with undifferentiated disease for future study. Rheumatologists play a key role in the evaluation of potential IPAF in patients, especially as many patients with a myositis-spectrum disease (e.g., non-Jo-1 antisynthetase syndrome, anti-melanoma differentiation-associated protein 5 antibody inflammatory myositis, or anti-PM/Scl antibody-associated inflammatory myositis) would be classified under IPAF using the currently available criteria for inflammatory myositis, and would therefore benefit from rheumatologic comanagement. The aim of this review was to describe the historical context that led to the development of these criteria and to discuss the limitations of the current criteria, diagnostic challenges, treatment options, and strategies for disease monitoring.
引用
- Wilfong EM, Lentz RJ, Guttentag A, et al. Interstitial Pneumonia With Autoimmune Features: An Emerging Challenge at the Intersection of Rheumatology and Pulmonology. Arthritis Rheumatol. 2018. PMID: 30058242. doi:10.1002/art.40679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。